Aubagio (oh-BAH-gee-oh, teriflunomide), the third ORAL option for treating multiple sclerosis (MS)

You'll hear about Aubagio (oh-BAH-gee-oh, teriflunomide), the third ORAL option for treating multiple sclerosis (MS).

Think of Aubagio as similar to Gilenya (fingolimod) and Tecfidera (dimethyl fumarate). All work to reduce disease relapses.

Expect some patients to receive Aubagio instead of Gilenya or Tecfidera. Aubagio doesn't carry the same heart risks as Gilenya...and is dosed once daily instead of twice daily like Tecfidera.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote